Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 38 for “"Orlistat"”.

  1. Untersuchung von Topiramat, Rimonabant, Orlistat und neuer Forschungschemikalien in verschiedenen Fettsuchtmodellen an Ratten

    … SLV319 in Kombination mit dem Lipasehemmer Orlistat (Xenical®), auf Körpergewichtsentwicklung, Futter- und Wasseraufnahme, Blutwerte und Zusammensetzung der Tierkörper untersucht. Die Tiere wurden über einen Zeitraum von 4 Wochen einmal täglich mit Vehikel 1 (CMC) oder SLV319 (3 oder 10 …

    lmu-germany Repository record for Untersuchung von Topiramat, Rimonabant, Orlistat und neuer Forschungschemikalien in verschiedenen Fettsuchtmodellen an Ratten (opens in a new tab)

  2. Dieta, atividade autonômica e efeitos do orlistat em pacientes com síndrome dos ovários policísticos

    … farmacêuticas podem ser necessárias. O orlistat é um fármaco usado no tratamento da obesidade que age através da inibição das lipases gástricas e pancreáticas e não tem efeitos adversos sistêmicos, sendo o único fármaco antiobesidade disponível em muitos países. Dessa forma, com o …

    brazil-ufrgs Repository record for Dieta, atividade autonômica e efeitos do orlistat em pacientes com síndrome dos ovários policísticos (opens in a new tab)

  3. Molecular mechanism of orlistat hydrolysis by the thioesterase of human fatty acid synthase for targeted drug discovery

    … the treatment of cancers. It has been shown that orlistat, an FDA approved drug for weight loss, inhibits the thioesterase (TE) of FASN, but can be hydrolyzed by TE. To understand the mechanisms of TE action and for designing better FASN inhibitors, I examined the mechanism of orlistat hydrolysis …

    iupui Repository record for Molecular mechanism of orlistat hydrolysis by the thioesterase of human fatty acid synthase for targeted drug discovery (opens in a new tab)

  4. In vitro examination of the effect of orlistat on the ability of the faecal microbiota to utilize dietary lipids

    Orlistat is an anti-obesity treatment with which several gastrointestinal (GI) side-effects are commonly associated in the initial stages of therapy. There is no physiological explanation as to why two-thirds of those who take the drug experience one or more side-effects. It has been hypothesized …

    westminster

  5. In vitro examination of the effect of orlistat on the ability of the faecal microbiota to utilize dietary lipids

    Orlistat is an anti-obesity treatment with which several gastrointestinal (GI) side-effects are commonly associated in the initial stages of therapy. There is no physiological explanation as to why two-thirds of those who take the drug experience one or more side-effects. It has been hypothesized …

    westminster

  6. Fatty acid required for glucose-induced change in beta cell plasma membrane potential leading to insulin secretion

    … to amplify secretion through varied mechanisms. Orlistat, a lipase inhibitor, blocks GSIS although the mechanism has not been clearly elucidated. We show that orlistat can also inhibit basal insulin secretion. FA can prevent/reverse orlistat-induced inhibition of secretion but fails to amplify …

    bu Repository record for Fatty acid required for glucose-induced change in beta cell plasma membrane potential leading to insulin secretion (opens in a new tab)

  7. Συγκριτική μελέτη της χορήγησης της ορλιστάτης και της σιμπουτραμίνης σε παχύσαρκες γυναίκες με το σύνδρομο των πολυκυστικών ωοθηκών

    … through the administration of two drugs, orlistat and sibutramine. Orlistat is a drug that acts peripherally in the absorption of fat in food, causing reversible gastrointestinal lipase inhibition without affecting the activity of other enzymes such as trypsin, chymotrypsin, amylase and …

    greece Repository record for Συγκριτική μελέτη της χορήγησης της ορλιστάτης και της σιμπουτραμίνης σε παχύσαρκες γυναίκες με το σύνδρομο των πολυκυστικών ωοθηκών (opens in a new tab)

  8. Inibidor de tripsina isolado de sementes de tamarindo como potencial agente terapêutico sobre a lipase pancreática e obesidade: um estudo in vitro e in vivo

    … obese and hyperfed animals treated with Orlistat (50 mg/kg Orlistat); obese and hyperfed animals treated with TTI (25 mg/L TTI); and obese and normofed animals treated with TTI (25 mg/L TTI). After 10 days of treatment, the groups were evaluated for lipase activity, body weight, and lipid …

    brazil-ufrn Repository record for Inibidor de tripsina isolado de sementes de tamarindo como potencial agente terapêutico sobre a lipase pancreática e obesidade: um estudo in vitro e in vivo (opens in a new tab)

  9. Pharmacotherapy and weight management: efficacy and clinical effectiveness in patients with obesity and type 2 diabetes

    … or ≥28 kg/m2 in patients with comorbidities, orlistat can be considered as a drug intervention on a case-by-case basis following a full risk and benefit assessment. The objective of the Glasgow and Clyde Weight Management Service (GCWMS), a specialist weight-loss programme, is for patients to …

    glasgow Download PDF for Pharmacotherapy and weight management: efficacy and clinical effectiveness in patients with obesity and type 2 diabetes (opens in a new tab)

  10. Response Surface Method for Recovering Flavonoid / Flavonone Rich Small Red Bean Extracts that Inhibit of α-Amylase, α-Glucosidase and Lipase in Isolation and Combined with Acrobose and Orlistat

    … with the pharmaceutical drugs, acarbose and orlistat. All three Extracts could potentiate inhibition caused by acarbose or orlistat at select levels. Extract 2, 9, and 11, were identified by high-performance liquid chromatography (HPLC) and consisted of gallic, chlorogenic, caffeic acids and …

    nebraska Repository record for Response Surface Method for Recovering Flavonoid / Flavonone Rich Small Red Bean Extracts that Inhibit of α-Amylase, α-Glucosidase and Lipase in Isolation and Combined with Acrobose and Orlistat (opens in a new tab)

  11. Treatment of adult obesity

    … the long-term treatment of obesity. Those are orlistat, lorcaserin and phentermine/topiramate. The surgical treatments reviewed include vertical banded gastroplasty, adjustable gastric banding, Roux-en Y gastric bypass, biliopancreatic diversion, and biliopancreatic diversion with duodenal …

    bu Repository record for Treatment of adult obesity (opens in a new tab)

  12. Combining microfluidics with raman spectroscopy for the study of emerging cancer therapies

    … treated with the fatty acid synthase inhibitor Orlistat or steroyl-CoA desaturase inhibitor CAY10566. Raman spectroscopy revealed a significant increase in lipid content for PC3 cells treated with Orlistat (p < 0.0001), but not for PNT2 cells, nor for either cell line treated with CAY10566. In …

    strathclyde Repository record for Combining microfluidics with raman spectroscopy for the study of emerging cancer therapies (opens in a new tab)

  13. Discovery of a Novel Signaling Circuit Coordinating Drosophila Metabolic Status and Apoptosis

    … of Dronc, as both the chemical inhibitor orlistat and FASN dsRNA abrogated NADPH-mediated protection against CHX-induced apoptosis in S2 cells. Interestingly, it has been previously demonstrated that blocking FASN induces cell death in numerous cancers, including ovarian cancer; however, …

    duke Repository record for Discovery of a Novel Signaling Circuit Coordinating Drosophila Metabolic Status and Apoptosis (opens in a new tab)

  14. Eficacia y seguridad de liraglutida para manejo de sobrepeso y obesidad. Revisión sistemática y Metaanálisis en red

    … difference -5.28 [-5.49, -5.07]) and against Orlistat, showed a higher proportion of patients with loss of 5% or more of body weight (OR 4.02 [2.14, 7.52]). In the indirect comparison, Lorcaserin OR 3.77 (95% CI 3.17, 4.44) and Topiramate / Phentermine OR 2.03 (95% CI 1.65, 2.55) showed a …

    rosario Repository record for Eficacia y seguridad de liraglutida para manejo de sobrepeso y obesidad. Revisión sistemática y Metaanálisis en red (opens in a new tab)

  15. UPTAKE OF PHARMACEUTICALS INTO TERRESTRIAL ORGANISMS

    … namely carbamazepine, diclofenac, fluoxetine and orlistat into the earthworm, Eisenia fetida. Pore water based bioconcentration factors (BCFs) increased in the order of carbamazepine < diclofenac < fluoxetine and orlistat. As well as experimental research, a desk based investigation was perfomed …

    whiterose Download PDF for UPTAKE OF PHARMACEUTICALS INTO TERRESTRIAL ORGANISMS (opens in a new tab)

  16. CHARACTERISATION OF LIPASE INHIBITORS IN CRUCIFEROUS AND MORNING GLORY FAMILY VEGETABLES

    … the consumption of the anti-obesity drug, Orlistat is accompanied with undesirable gastrointestinal effects. Therefore, this research aims to screen and characterise vegetables that contain PL inhibitors as an alternative treatment. Based on this research, vegetables from the Brassicaceae …

    nus Repository record for CHARACTERISATION OF LIPASE INHIBITORS IN CRUCIFEROUS AND MORNING GLORY FAMILY VEGETABLES (opens in a new tab) Download file for CHARACTERISATION OF LIPASE INHIBITORS IN CRUCIFEROUS AND MORNING GLORY FAMILY VEGETABLES (opens in a new tab)

  17. Development of Lewis Base Catalyzed Stereoselective Methods for Synthesis of Beta- Lactones and Dyotropic Rearrangements of Tricyclic Beta-Lactones.

    … finding that the FDA-approved antiobesity agent orlistat (tetrahydrolipstatin, Xenical) is a potent inhibitor of the thioesterase domain of fatty acid synthase (FAS) led us to develop a concise and practical asymmetric route to pseudosymmetric 3,4-dialkyl-cis-beta-lactones. The well-documented …

    tamu Repository record for Development of Lewis Base Catalyzed Stereoselective Methods for Synthesis of Beta- Lactones and Dyotropic Rearrangements of Tricyclic Beta-Lactones. (opens in a new tab)

  18. Activity-based Chemical Proteomics Profiling of Natural Products and Drug-like Small Molecules

    … thesis, I describe the design and synthesis of orlistat-like natural product-based probes (Chapter 2, 3 and 4), K11777-like drug candidate-based probes (Chapter 5) and drug-like azadipeptide nitrile-based small molecules (Chapter 6), determination of structure-activity relationships of these …

    nus Repository record for Activity-based Chemical Proteomics Profiling of Natural Products and Drug-like Small Molecules (opens in a new tab) Download file for Activity-based Chemical Proteomics Profiling of Natural Products and Drug-like Small Molecules (opens in a new tab)

Page 1 of 2